# Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy

Study · id `cardio:ct-nct07511543` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07511543](<https://clinicaltrials.gov/study/NCT07511543>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07511543

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT07511543. Randomized; single masking; primary purpose treatment. Start 2026-10-31 (anticipated); primary completion 2028-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT07511543, source copy `cardio:ctgov-nct07511543-2026-09-24`, retrieved 2026-10-26)
- Planned start: 2026-10-31 (anticipated) (ClinicalTrials.gov record NCT07511543, source copy `cardio:ctgov-nct07511543-2026-09-24`, retrieved 2026-10-26)
- Primary completion: 2028-10-31 (anticipated) (ClinicalTrials.gov record NCT07511543, source copy `cardio:ctgov-nct07511543-2026-09-24`, retrieved 2026-10-26)
- Completion: 2029-01-31 (anticipated) (ClinicalTrials.gov record NCT07511543, source copy `cardio:ctgov-nct07511543-2026-09-24`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07511543-2026-09-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy
- Acronym: LEAST
- Condition: Ischemic Stroke
- Intervention (Drug): Semaglutide
- Lead sponsor: Population Health Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Semaglutide (`cardio:semaglutide`)
- Registry intervention is a member of this class by a sourced record link: GLP-1 receptor agonists (drug class) (`cardio:glp1-receptor-agonists`)
- Registry lists this organization as the lead sponsor: Population Health Research Institute (`cardio:org-population-health-research-institute`)

## Provenance

Content hash: 04c6500cb0090469981a002f13a55d8aac76762837406cf40789809fe9a59f74
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
